These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5078657)

  • 1. [Intravenous infusion of a standard coagulation-active phospholipid complex in uremic tendency to bleeding. Normalization of thrombin formation and prothrombin consumption].
    Schimpf K; Hanf-Hoppe HW; Immich H
    Med Welt; 1972 Sep; 23(37):1258-60. PubMed ID: 5078657
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous infusion of a standardised coagulation active phospholipid complex in uremic coagulation deficiency. Return to normal of thrombin generation and prothrombin consumption.
    Schimpf K; Hanf-Hoppe HW; Immich H
    Thromb Diath Haemorrh; 1972 Jul; 27(3):554-8. PubMed ID: 4662616
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of interaction between a phosphoinositide anticoagulant and a phospholipid activator in the Stypven type conversion of prothrombin to thrombin.
    Kahn MJ; Bourgain RH
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):273-6. PubMed ID: 4296603
    [No Abstract]   [Full Text] [Related]  

  • 4. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous and oral sulodexide versus coagulation activation markers in humans.
    Borawski J; Dubowski M; Rydzewska-Rosolowska A; Mysliwiec M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):596-8. PubMed ID: 19910295
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uremic tendencies for hemorrhage and hemodialysis].
    Vogel GE; Hansen W; Goldmann FL; Kopp KF
    Z Urol Nephrol; 1977 Dec; 70(12):895-900. PubMed ID: 607692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulant effect of phosphatidylserine].
    Tersenov OA; Chabanov MK
    Vopr Med Khim; 1981; 27(5):619-23. PubMed ID: 7314577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uremic coagulopathy. Role of thrombin].
    Camici M; Sagripanti A
    Minerva Urol Nefrol; 2000 Jun; 52(2):67-72. PubMed ID: 11085063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid requirements in thrombin formation.
    Zolton RP; Seegers WH
    Thromb Res; 1974 Mar; 4(3):437-46. PubMed ID: 4364365
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
    Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
    Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in blood coagulation during infusion of intralipid.
    Reid DJ; Ingram GI
    Clin Sci; 1967 Oct; 33(2):399-407. PubMed ID: 6058437
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-induced haemorrhagic diathesis in uraemia (author's transl)].
    Andrassy K; Ritz E; Trobisch W; Andrassy T
    Dtsch Med Wochenschr; 1973 Nov; 98(47):2247-9. PubMed ID: 4759521
    [No Abstract]   [Full Text] [Related]  

  • 17. [Various comments on thrombocytopathy acquired in uremic diseases].
    de Vries SI; ten Cate JW; den Hartog-Veerman ME; van Dooren MM
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1658-60. PubMed ID: 4880618
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.
    Thiagarajan P; Shapiro SS; De Marco L
    J Clin Invest; 1980 Sep; 66(3):397-405. PubMed ID: 6772673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.